-

Northlane Capital Partners’ Portfolio Company Discovery Data Names Robert Skea as Chief Executive Officer

EATONTOWN, N.J.--(BUSINESS WIRE)--Discovery Data, the leading provider of data and analytics on firms and professionals in the financial services and insurance industries, is pleased to announce the appointment of Robert Skea as the company’s new Chief Executive Officer.  

Mr. Skea brings a unique combination of financial technology and information services expertise accumulated over multiple successful tenures in executive roles at leading organizations. Most recently, Mr. Skea was a Managing Partner and Founder of Decklor Consulting Group.  Prior to that role, he led all revenue and client engagement at Dun & Bradstreet as the Head of Americas. He began his career at Chase Manhattan Bank and held C-level and senior management roles at Chase, ICE Data Services, Northstar Systems International and Reuters before Dun & Bradstreet.

 “The Discovery Data team has built a market-leading information services company providing unique datasets via a bespoke SaaS platform that helps professionals in the financial services and insurance industries make informed business decisions,” said Mr. Skea. “I look forward to building upon all the work that has taken place over the years at Discovery Data, and to continuing the strong partnership with Northlane Capital Partners, Discovery Data’s Board of Directors, and its Chairman, John Stanfill, the former CEO of RainKing Solutions.”

Sean Eagle, a partner at Northlane Capital Partners, said “We couldn’t be happier to have Bob join as CEO of Discovery Data.  His track record of innovation and customer service across multiple marquee brands in data and information services is an exciting development for Discovery Data’s customers, employees, and strategic partners.”

About Discovery Data

Discovery Data offers a consolidated view of the financial services and insurance industries, including all BD and RIA firms, over 725,000 reps, 2,200 trust companies and over 2 million insurance agents. Access to the firm’s data is provided via subscription to an online portal and through Discovery Data’s CRM and API integrations. In addition, Discovery Data is the industry leader in data hygiene services and expert in data-driven market insight, email marketing campaigns and outbound call center lead generation. Many of the world's largest and most successful institutions rely on Discovery Data to understand the industry, and to identify, reach and do business with firms and professionals throughout North America.

About Northlane Capital Partners

Based in Bethesda, MD, Northlane currently manages a $1 billion private equity fund investing in control buyouts of middle market companies based in North America. Northlane focuses on targeted segments of the healthcare and business services sectors and invests in companies with EBITDA of $5 million to $30 million. For more information, please visit http://www.northlanecapital.com.

Contacts

Discovery Data


Release Versions

Contacts

More News From Discovery Data

Northlane Capital Partners Announces Investment in Plus Delta Partners

CARLSBAD, Calif.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has made an investment in Plus Delta Partners (“PDP”), a leading provider of specialized fundraising training and tools designed to enable higher education institutions, healthcare organizations, and other nonprofits to maximize donor contributions. NCP invested alongside PDP’s management team and its founder, Guy Hart. PDP offers a comprehensive suite of fundraising training solutions tailored to fron...

Northlane Capital Partners Invests in United States Drug Testing Laboratories

DES PLAINES, Ill.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has invested in United States Drug Testing Laboratories Inc. (“USDTL”), a forensic toxicology laboratory testing for alcohol and substance use. NCP invested alongside USDTL’s management team and its founders, Veronica and Doug Lewis. USDTL is headquartered in Des Plaines, IL, and offers a broad suite of forensic testing capabilities. The company primarily serves hospitals, health systems, court system...

SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired IDEA Pharma (“IDEA”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. IDEA, headquartered in London, United Kingdom, specializes in pharmaceutical path-to-market strategy and innovation. This acquisition strengthens SAI’s ca...
Back to Newsroom